Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients
Prof. Sathkege will share his long-standing experience in the clinics with 225Ac in prostate cancer patients and its challenges.
Sunday 11 am - Full & Monday 9.30 am - Full
Prof. Mike Sathekge Professor and Head of Nuclear Medicine Department at University of Pretoria and Steve Biko Academic Hospital
The Challenge of 225Ac Early Supply and Commercial Supply
Dr. Van den Berghe will share about the recent developments in PanTera, the IBA – SCK CEN joint venture, notably how they plan to make available an Early Supply of 225Ac available while building their facility for large-scale & high-quality Commercial Supply.
Sunday 3 pm - Full& Monday 3.45 pm - Full
Sven Van den Berghe Ph.D. CEO of Pantera
Enhancing Access to Radiotheranostics for cancer care worldwide
Dr Viana and Mrs. Tala Allahaam will share how this non-profit organisation supports the developpement and raises awareness of radiotheranostics worldwide.
Monday 11.30 am - Full
Alice Viana, Ph.D. Development Manager at Oncidium Foundation